ArticleBiomedicines2025

In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration.

Andrew J Kocab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.